Beta
21 CFR § 862.1090
21 CFR § 862.1090 — § 862.1090 Angiotensin converting enzyme (A.C.E.) test system.
Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.
Analyze this law with AI§ 862.1090 Angiotensin converting enzyme (A.C.E.) test system.
(a) Identification. An angiotensin converting enzyme (A.C.E.) test system is a device intended to measure the activity of angiotensin converting enzyme in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of diseases such as sarcoidosis, a disease characterized by the formation of nodules in the lungs, bones, and skin, and Gaucher's disease, a hereditary disorder affecting the spleen.
(b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
[52 FR 16122, May 1, 1987, as amended at 84 FR 71796, Dec. 30, 2019]
